OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ORPP56

Orient Paper and Industries Ltd

Paper ProductsVerified

Orient Paper and Industries Ltd has a liquidity risk profile marked by a current ratio of 0.8, indicating that its current assets are less than its current liabilities, and a negative net cash position after subtracting total debt. The company's liquidity_fpt score is low, suggesting potential challenges in meeting short-term obligations without external financing. The company's profitability is underperforming, with a return on equity of -3.56% and a return on assets of -2.27%, both significantly below the industry median for the Paper Products sector. Operating income and net income are negative, indicating a loss-making position in the latest reporting period. Orient Paper and Industries Ltd operates in two primary segments: paper and tissue, and chemicals. The paper and tissue segment is its core business, with a focus on tissue jumbo rolls for tissue converters. The chemicals segment, while smaller, contributes to the company's revenue through the sale of caustic soda and other industrial chemicals. The company's geographic exposure is primarily domestic, with a significant portion of its sales occurring within India. The company's growth trajectory is constrained, with a negative operating cash flow and free cash flow, and capital expenditures of INR 651.2 million. The outlook for the current fiscal year indicates a continuation of financial pressures, with no significant improvement in revenue or profitability expected in the near term. The risk assessment for Orient Paper and Industries Ltd highlights a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 0.26 is relatively low, but the negative net cash position and operating losses pose a risk to its financial stability. The risk of dilution is low, as the number of shares outstanding has not changed significantly. Recent events and filings indicate that the company is facing operational and financial challenges. The latest financial snapshot shows a decline in profitability and liquidity, with a negative operating income and net income. The company's capital expenditures suggest ongoing investment in its operations, but the lack of positive cash flow from operations may limit its ability to fund these investments internally.

30-day price · ORPP+3.16 (+20.8%)
Low$13.25High$20.34Close$18.32As of12 May, 00:00 UTC
Profile
CompanyOrient Paper and Industries Ltd
TickerORPP.NS
SectorBasic Materials
BusinessApplied Resources
Industry groupApplied Resources
IndustryPaper Products
AI analysis

Business. Orient Paper and Industries Ltd is engaged in the manufacturing and sale of paper and paper-related products, including pulp, tissue jumbo rolls, and chemicals such as caustic soda and hydrochloric acid, primarily serving tissue converters in India and international markets.

Classification. Orient Paper and Industries Ltd is classified under the Basic Materials economic sector, Applied Resources business sector, and Paper Products industry, with a classification confidence of 0.92.

Orient Paper and Industries Ltd has a liquidity risk profile marked by a current ratio of 0.8, indicating that its current assets are less than its current liabilities, and a negative net cash position after subtracting total debt. The company's liquidity_fpt score is low, suggesting potential challenges in meeting short-term obligations without external financing. The company's profitability is underperforming, with a return on equity of -3.56% and a return on assets of -2.27%, both significantly below the industry median for the Paper Products sector. Operating income and net income are negative, indicating a loss-making position in the latest reporting period. Orient Paper and Industries Ltd operates in two primary segments: paper and tissue, and chemicals. The paper and tissue segment is its core business, with a focus on tissue jumbo rolls for tissue converters. The chemicals segment, while smaller, contributes to the company's revenue through the sale of caustic soda and other industrial chemicals. The company's geographic exposure is primarily domestic, with a significant portion of its sales occurring within India. The company's growth trajectory is constrained, with a negative operating cash flow and free cash flow, and capital expenditures of INR 651.2 million. The outlook for the current fiscal year indicates a continuation of financial pressures, with no significant improvement in revenue or profitability expected in the near term. The risk assessment for Orient Paper and Industries Ltd highlights a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 0.26 is relatively low, but the negative net cash position and operating losses pose a risk to its financial stability. The risk of dilution is low, as the number of shares outstanding has not changed significantly. Recent events and filings indicate that the company is facing operational and financial challenges. The latest financial snapshot shows a decline in profitability and liquidity, with a negative operating income and net income. The company's capital expenditures suggest ongoing investment in its operations, but the lack of positive cash flow from operations may limit its ability to fund these investments internally.
Key takeaways
  • Orient Paper and Industries Ltd is experiencing a liquidity crunch with a current ratio of 0.8 and negative net cash after debt.
  • The company's profitability is severely underperforming, with a return on equity of -3.56% and a return on assets of -2.27%.
  • The company's business is concentrated in the domestic market, with a primary focus on the paper and tissue segment.
  • Growth is constrained by negative operating and free cash flows, with capital expenditures not being offset by positive cash generation.
  • The company's debt-to-equity ratio is low, but the negative net cash position and operating losses pose a risk to its financial stability.
  • Recent financial reports indicate ongoing operational and financial challenges, with no significant improvement in the near term.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$8.96B
Gross profit$2.89B
Operating income-$617.7M
Net income-$546.6M
R&D
SG&A
D&A
SBC
Operating cash flow-$122.5M
CapEx-$651.2M
Free cash flow-$737.7M
Total assets$24.08B
Total liabilities$8.73B
Total equity$15.35B
Cash & equivalents
Long-term debt$4.00B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$8.96B-$617.7M-$546.6M-$737.7M
FY-1$8.32B$229.0M$62.3M-$1.29B
FY-2$9.43B$1.33B$992.5M-$28.5M
FY-3$5.86B-$449.6M-$288.8M-$1.29B
FY-4$4.43B-$630.8M-$465.5M-$438.6M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$24.08B$15.35B
FY-1$24.26B$16.19B
FY-2$22.04B$15.15B
FY-3$21.73B$15.53B
FY-4$19.60B$14.68B
PeriodOCFCapExFCFSBC
FY0-$122.5M-$651.2M-$737.7M
FY-1$1.01B-$1.58B-$1.29B
FY-2$617.7M-$1.30B-$28.5M
FY-3-$244.8M-$1.26B-$1.29B
FY-4-$200.0M-$190.7M-$438.6M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$2.36B-$252.2M-$212.6M
FQ-1$2.00B-$464.4M-$306.0M
FQ-2$2.38B-$125.2M$339.9M
FQ-3$2.19B-$237.6M-$180.7M
FQ-4$2.30B-$139.8M-$105.1M
FQ-5$2.08B-$302.1M-$196.6M
FQ-6$2.38B-$42.4M-$64.2M
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1$22.15B$15.55B$6.7M
FQ-2
FQ-3$24.08B$15.35B$7.4M
FQ-4
FQ-5$25.37B$17.20B$9.1M
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1-$115.0M-$406.1M
FQ-2
FQ-3-$122.5M-$651.2M
FQ-4
FQ-5$213.6M-$360.5M
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$15.35B
Net cash-$4.00B
Current ratio0.8
Debt/Equity0.3
ROA-2.3%
ROE-3.6%
Cash conversion22.0%
CapEx/Revenue-7.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Paper Products · cohort 128 companies
MetricORPPActivity
Op margin-6.9%3.2% medp25 -3.0% · p75 6.6%bottom quartile
Net margin-6.1%1.6% medp25 -3.7% · p75 5.0%bottom quartile
Gross margin32.2%16.0% medp25 10.4% · p75 25.9%top quartile
CapEx / revenue-7.3%-5.6% medp25 -10.5% · p75 -1.7%below median
Debt / equity26.0%56.5% medp25 23.2% · p75 97.4%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 00:28 UTC#15779e36
Source: analysis-pipeline (hybrid)Generated: 2026-05-12 00:31 UTCJob: 305fe0e2